Interleukin Inhibitors Market: Growth, Opportunities, and Future Trends 2030
A growing older population, an increase in the prevalence of autoimmune diseases worldwide, and technological advancements in the creation of new interleukin inhibitors are some of the main factors propelling the market's growth. The treatment of autoimmune diseases has also undergone a substantial change. Because of their enhanced safety and efficacy features, targeted treatments are growing in popularity, which is anticipated to support market growth.